4D Path, a pioneer in image analysis and developer of the 4D Q-Plasia Oncoreader (QPOR)™, today confirmed its formal membership of Leeds Teaching Hospitals NHS Trust’s Innovation Pop-Up in the UK.
Recently celebrating its two-year anniversary since start up in October 2023; the Innovation Pop-Up at Leeds Teaching Hospital is a growing international community of high-tech start-ups led by clinicians, scientists, and entrepreneurs that provides a valuable test bed for new innovations, technologies, and ways of working within a real-life clinical environment before they are implemented in the NHS.
4D Path collaborates with a broad array of clinical and life science partners to advance the field of precision medicine through groundbreaking cancer diagnostic technology.
4D Path is currently working with the NHS Histopathology department, the University of Leeds, and the University of Bradford to validate its platform, which aims to improve access to precision medicine in oncology by providing more accurate and quantitative diagnoses, faster case review times, and higher throughput at lower cost than traditional methods, thereby improving patient outcomes and experiences.
4D Path’s diagnostic platform is designed to use statistical physics and cell cycle dynamics to provide pathologists with insights into tumors’ underlying cancer biology from digitized histopathology images.
To date, 4D Path has conducted several breast cancer investigations at the University of Leeds using its 4D Q-Plasia OncoReader Breast platform, with plans to expand the remit of current trials across a range of other malignancies, including skin, lung, gynecological, and head and neck cancers. 4D Path will look to update and present its future findings at upcoming international Oncology Conferences and to identify future applications for this important diagnostic advancement.
About 4D Path
Just because you can’t see something, doesn’t mean it’s not there. 4D Path’s mission is to transform precision diagnostics by using statistical physics and cell cycle dynamics to unveil previously hiddeninformationin cellular snapshots of tissue.The company’s cloud-based 4D Q-Plasia OncoReader™ (QPOR) is a U.S. patented pan-cancer platform, which has also been awarded FDA Breakthrough Device Designation for its Breast Cancer-specific QPOR. This digital image-to-report solution providesatool whichaims toimprovediagnostic accuracy of existing biomarkers, identify new biological signatures to guide therapeutic management, accelerate diagnostic turnaround times, and reduce costsin a single step. 4D Path collaborates with a broad array of clinical and life science partners to advance the field of precision medicine through groundbreaking cancer diagnostic technology.Visitwww.4dpath.com or contact Lisa Williams, lwilliams@4DPath, to learn more.
About Leeds Teaching Hospitals NHS Trust, Innovation Pop Up (Boiler Plate) and Building the Leeds Way
The Leeds Teaching Hospitals NHS Trust Innovation Pop Up brings together entrepreneurs, researchers and clinicians to create, evaluate and adopt new products and services to transform health and social care and drive economic growth. Launched in October 2021 the Innovation Pop Up is at the heart of the Leeds Teaching Hospitals NHS Trust’s future ‘Building the Leeds Way’ programme to create a new Innovation Village, a new home for Leeds Children’s Hospital, a new hospital for adults and the UK’s largest single-site maternity centre and neonatal unit as part of the whole site transformation of the Leeds General Infirmary (LGI) site. The future programme of capital investment and improvements as part of the UK Government’s new hospitals programme is expected to bring direct and wider economic benefits of almost £13billion in net present value to the city, along with around 4,000 jobs and 520 new homes. As a first stage in that development, in September 2023, the programme saw the official launch of the now completed state of the art ‘Centre for Laboratory Medicine’ at St James University Hospital.
Leeds Teaching Hospitals NHS Trust is one of the largest and busiest acute hospital trusts in Europe. Every year Leeds Teaching Hospitals NHS Trust provides healthcare and specialist services for people from the city of Leeds, Yorkshire, and the Humber and beyond. We play an important role in the training and education of medical, nursing, and dental students, and are a centre of world-class research and pioneering new treatments. With a budget of over £1.6 billion and employing over 20,000 people, last year (2021/2022) there were over 1.7 million patient attendances across the Trust’s Hospitals. Care and clinical expertise is delivered from seven hospitals on five sites, and they are all joined by a vision to be the best for specialist and integrated care. Treatments and episodes of care includes 86,000 day cases, 23,000 inpatients, 175,000 attendances to our Emergency Departments and 935,000 outpatient appointments. Visit www.leedsth.nhs.uk to find out more.